3-Pyrimidin-2-yl-Propionic Acid

  • CAT Number: R012970
  • CAS Number: 439108-20-0
  • Molecular Formula: C7H8N2O2
  • Molecular Weight: 152.153
  • Purity: ≥95%
Inquiry Now

3-<wbr />Pyrimidin-<wbr />2-<wbr />yl-<wbr />Propionic Acid(CAS: 439108-20-0) is a synthetic intermediate useful for pharmaceutical synthesis.

Catalog Number R012970
CAS Number 439108-20-0
Synonyms

2-pyrimidinepropanoic acid

Molecular Formula

C7H8N2O2

Purity 95%
Storage -20°C
IUPAC Name 3-pyrimidin-2-ylpropanoic acid
InChI InChI=1S/C7H8N2O2/c10-7(11)3-2-6-8-4-1-5-9-6/h1,4-5H,2-3H2,(H,10,11)
InChIKey UXTNNDRHOGJJFE-UHFFFAOYSA-N
SMILES C1=CN=C(N=C1)CCC(=O)O
Reference

[1]. Stock, N., Baccei, C., Bain, G., Broadhead, A., Chapman, C., Darlington, J., King, C., Lee, C., Li, Y., Lorrain, D.S. and Prodanovich, P., 2010.<br />
5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2, 3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2, 2-dimethyl-propionic acid (AM679)&mdash;A potent FLAP inhibitor.<br />
Abstract: AM643 (compound 6, 3-{3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid) was identified as a potential candidate for formulation as a topical agent for the treatment of skin disorders involving leukotriene production. Dermal application of 6 using a prototypical vehicle in a murine ear arachidonic acid model showed significant reduction in the concentrations of leukotrienes in mouse skin with concomitant reduction in ear swelling.<br />
Bioorganic &amp; medicinal chemistry letters, 20(1), pp.213-217.<br />
<br />
[2]. El-Ahl, A.A., Ismail, M.A. and Amer, F.A., 2003.<br />
Synthesis and Transformations of 2-Substituted Tetrahydro-4 H-benzo [4, 5] thieno [2, 3-d][1, 3] oxazines and 2, 3-Disubstituted Hexahydrobenzo [4, 5] thieno [2, 3-d] pyrimidines.<br />
Abstract: 3-(4-Oxo-5,6,7,8-tetrahydro-4 H -benzo[4,5]thieno[2,3-d][1,3]oxazin-2-yl)propanoic acid and its ethyl ester 6a , b have been prepared via succinoylation of ethyl 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 1 , followed by ester hydrolysis, selective esterification, and acetic anhydride induced cyclization of the thiophenecarboxylic acid derivatives 3 , 5 . Reaction of 1 with diethyl malonate gave the malonic acid diamide 7 , which on ester hydrolysis followed by acetic anhydride induced water elimination furnished the 2-substituted 4 H -benzo[4,5]thieno[2,3-d][1,3]oxazine derivative 10 in high yield. A series of new benzo[4,5]thieno[2,3-d]pyrimidines 11-19 , which bear a propanoic acid substituent in the 2-position and an amino, aryl, aminosugar, and arylmethylideneamino-substituents in the 3-position have been prepared via the reaction of 6a , b with hydrazine hydrate or aromatic amines followed by treatment with aromatic aldehydes, isatin, or aldoses. The aldimines 18a-d underwent unprecedented acid catalyzed tandem cyclization-transannular aldehyde extrusion into octahydro-1 H -benzo[4&#39;,5&#39;]thieno[2&#39;,3&#39;:4,5]pyrimido[1,2-b]pyridazines 21 . Two other unequivocal approaches for 21 also have been explored, either by treatment of the amino acid derivative 11 with thionyl chloride or by thermal cyclization of the amino ester derivative 12 .<br />
Phosphorus, Sulfur, and Silicon and the Related Elements, 178(2), pp.245-259.<br />
<br />
[3]. Panico, A., Cardile, V., Santagati, A. and Gentile, B., 2001.<br />
Thienopyrimidine derivatives prevent cartilage destruction in articular disease.<br />
Abstract: The effects of a series of thienopyrimidine derivatives on the prevention of cartilage destruction in articular disease were investigated. Anti-degenerative activity was assayed on culture of nasal pig cartilage in the presence or in the absence of interleukin 1&beta; (IL-1&beta;). The amount of glycosaminoglycans (GAGs) and the production of nitric oxide (NO) in the culture medium were determined. Some thienopyrimidine derivatives, in the presence of IL-&beta;, blocked the cartilage breakdown by inhibiting both the NO production and GAGs release in a dose-dependent manner.<br />
Il farmaco, 56(12), pp.959-964.

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!